The Russian Ministry of Health has registered the domestic allergen vaccine "Allergarda"

The Russian Ministry of Health announced the registration of the domestic allergy vaccine Allergarda.

The Allergarda vaccine is contraindicated in patients with autoimmune, immune complex and cardiovascular diseases, as well as in patients treated with beta-blockers, including eye drops.

The administration of the Allergarda vaccine should be postponed to persons with acute infectious and non-infectious diseases, exacerbation of chronic diseases.

MOSCOW, October 3 - RIA Novosti. The Allergarda allergy vaccine is contraindicated for patients with autoimmune, immune complex and cardiovascular diseases, as well as for treatment with beta-blockers, including eye drops, according to the instructions for the drug, which is available to RIA Novosti.

On Wednesday, the Russian Ministry of Health announced the registration of the domestic allergen vaccine "Allergarda" for the prevention and treatment of allergic rhinoconjunctivitis.

According to the document, the drug is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients, autoimmune and immune complex diseases, primary and secondary immunodeficiencies, cardiovascular diseases, malignant neoplasms and blood diseases, uncontrolled or severe bronchial asthma (FEV1 less than 70% against the background of adequate pharmacotherapy).

Also, Allergarda is not recommended for treatment with beta-blockers, including topical forms: eye drops, gels, ointments. And among other things, in the presence of a history of anaphylactic shock during ASIT, exacerbation of the underlying disease and in patients taking tricyclic antidepressants and monoamine oxidase inhibitors.